Vaccines have become one of the most powerful weapons against Covid-19. Vaccines have been shown to reduce the risk of severe illness and hospitalization. The latest, this weapon is also said to be able to reduce a person’s risk of experiencing long-term Covid-19 symptoms long Covid.
“We found that the likelihood of having symptoms 28 days or more after post-vaccination infection was reduced by about half with two full doses. These results suggest that the risk of long-standing Covid is reduced in individuals who have received full vaccination,” the researchers wrote in the study published in the journal The Lancet Infectious Diseases on Wednesday.
Researchers from institutions in the US and UK analyzed self-reported data from adults in the UK who shared Covid-19 symptoms using an app called Covid Symptom Study.
The researchers examined the symptoms reported by app users who said they had received the vaccine between December 8, 2020 and July 4, 2021. They compared the symptoms of those who had been vaccinated with those who had not.
In this study, more than 1.2 million people who had taken the first dose were involved. Among them, there were 0.5 percent or 6,030 people who tested positive for the breakthrough corona virus after receiving the first dose. Of the nearly 1 million adults who reported receiving a second dose of the vaccine, only 0.2 percent, or 2,370, tested positive after receiving two doses.
The researchers found that some groups were more susceptible to breakthrough infections, especially after the first dose of vaccine. This group includes those aged 60 years or over who are considered weak and people who live in “very deprived” areas, such as densely populated areas. The data also show that those who are not obese have a lower chance of infection after the first dose of vaccine.
Overall, however, the researchers found that all age groups who had been vaccinated were associated with fewer reports of COVID-19 symptoms when contracting the SARS-Cov-2 virus.
The researchers found that vaccination, compared to not vaccinated, was associated with a reduced risk of being hospitalized for Covid-19 or having more than five symptoms in the first week of illness after receiving the first or second dose. There was also a reduction in the likelihood of long-term symptoms lasting 28 days or more after the second dose of vaccine.
“Almost all individual symptoms of Covid-19 were less common in vaccinated and non-vaccinated participants. More people in the vaccinated group were asymptomatic at all than the unvaccinated,” wrote the researchers.
Well, so what are you waiting for. Hurry up and register yourself to get the Covid-19 vaccination. In addition to getting protection from the corona virus, vaccines also make you more free to do activities, such as shopping at the mall.